CTRI/2026/07/113754进行中（未招募）2 期
A Pilot clinical study to evaluate the safety and efficacy of Neelanjana Mai for the management of Vellai Patalam Senile Cataract - NIL
Central Council for Research in Siddha0 个研究点目标入组 5 人开始时间: 2026年7月20日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of both the sex who met the diagnostic standards of senile cataract Patients dignosed with cataracts on slitlamp microscopy of any type of cataract within the grade of less than Grade 2 or equal to grade 2
排除标准
- •Patients suffering from congenital cataracts hypemature cataracts glaucoma diabetic retinopathy macular degenration and retinitis pigmentosa Patients whose random blood sugar levels and blood pressure are not within normal limits Patients who are under steroid treatment and or any kind of immunosuppressive theraphy or under any cataract inducing medication will be excluded Patients with a grading of more than Grade2 under Slit Lamp mictoscope will exclude the study
研究者
相似试验
尚未招募
不适用
A study of risvutatug rezetecan in combination with ivonescimab in participants with advanced solid tumors (EMBOLD PanTumour-103)Solid TumorsjRCT2031260379184
招募中
2 期
A study to investigate the safety and clinical activity of belantamab for the treatment of multiple myeloma when used as monotherapy and in combination treatments.Multiple myeloma2022-501941-63-00Glaxosmithkline Research & Development Limited3
招募中
1 期
A clinical study to investigate the safety, tolerability and pharmacokinetic profile of single ascending concentrations of OPT101 in peritoneal dialysis patients.Chronic kidney disease2025-522966-61-00OPTERION Health AG12
招募中
不适用
A clinical study to confirm the efficacy and safety of hard contact lenses for vision correction (SS-200)Corneal astigmatismjRCT203226029030
招募中
不适用
An observational study to verify the safety and effectiveness of treatment using organic iodine + MD(alpha) for patients with advanced cancer (stage 3 or later) using standard and advanced test indicatorsCancerjRCT103026001610